THERAPEUTIC AGENTS FOR NEURODEGENERATIVE DISEASES Russian patent published in 2021 - IPC A61K31/198 A61P25/14 A61P25/16 A61P25/28 

Abstract RU 2763425 C2

FIELD: medicine.

SUBSTANCE: invention relates to the use of leucine, acetyl-leucine or their pharmaceutically acceptable salts for the treatment of a restless leg syndrome.

EFFECT: obtaining therapeutic agents for the treatment of neurodegenerative diseases.

11 cl, 14 dwg, 35 tbl, 22 ex

Similar patents RU2763425C2

Title Year Author Number
THERAPEUTIC AGENTS AGAINST NEURODEGENERATIVE DISEASES 2017
  • Strupp, Michael
RU2756519C2
PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS AGAINST LYSOSOMAL STORAGE DISEASES 2017
  • Shtrup, Mikhael
RU2749515C2
DEUTERATED ANALOGUES OF ACETYLEUCINE 2019
  • Mann, Michiko
RU2810793C2
LEUCINE, ACETYLLECINE AND RELATED ANALOGUES FOR TREATMENT OF DISEASE 2020
  • Factor, Mallory
  • Fields, Taylor
RU2815373C2
THERAPEUTIC AGENTS FOR THE TREATMENT OF RESTLESS LEG SYNDROME 2019
  • Factor, Mallory
  • Strupp, Michael
RU2802288C2
ACETYL LEUCINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT FOR IMPROVING THE MOTOR FUNCTION AND THE COGNITIVE FUNCTION 2017
  • Fektor, Mellori
  • Shtrup, Mikhael
RU2745912C2
TREATMENT OF MIGRAINE 2018
  • Strupp, Michael
  • Factor, Mallory
RU2772278C2
COMBINATION OF ACETYLLEICINE FOR TREATMENT OF DIZZINESS 2017
  • Syrov Kirill Konstantinovich
  • Nesteruk Vladimir Viktorovich
  • Zamergrad Maksim Valerevich
RU2680413C1
DPP-IV INHIBITORS FOR TREATMENT OF NEURODEGENERATION AND COGNITIVE DISORDERS 2005
  • Kh'Juz Tomas Ehduard
RU2394570C2
METHOD FOR TREATING MITOCHONDRIAL DISORDERS 2000
  • Navioks Robert K.
RU2268732C2

RU 2 763 425 C2

Authors

Factor, Mallory

Dates

2021-12-29Published

2018-02-15Filed